Skip to main content
logo
Sea Mild Biotechnology Co., Ltd. (TPEX:7516)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
8.65
-0.11 (-1.26%)
Aug 14, 2026, 1:13 PM CST

Sea Mild Biotechnology Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
341.94341.94318.82257.02202.65163.82
Revenue Growth
-1.87%7.25%24.05%26.83%23.71%-21.20%
Gross Profit
89.289.291.2856.3736.1619.09
Operating Income
7.227.2222.284.83-11.98-31.99
Net Income
8.848.8431.996.19-21.38-52.05
Earnings Per Share
0.460.461.660.32-1.11-2.70
EPS Growth
-58.77%-72.37%417.70%---

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
89.289.282.9446.6340.5838.95
Total Debt
109.44109.4457.4244.2525.3525.16
Net Cash (Debt)
-20.24-20.2425.522.3815.2313.79
Net Cash Growth
--974.65%-84.40%10.45%-23.54%
Net Cash Per Share
-1.05-1.051.320.120.790.71

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
7.637.6334.258.8411.71-12.35
Capital Expenditures
-15.02-15.02-11.28-1.25--2.85
Free Cash Flow
-7.39-7.3922.977.5911.71-15.2
Free Cash Flow Growth
--202.56%-35.16%--

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
26.09%26.09%28.63%21.93%17.84%11.65%
Operating Margin
2.11%2.11%6.99%1.88%-5.91%-19.53%
Pretax Margin
2.57%2.57%10.33%2.39%-10.60%-25.64%
Profit Margin
2.58%2.58%10.03%2.41%-10.55%-31.77%
FCF Margin
-2.16%-2.16%7.20%2.95%5.78%-9.28%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
24.8922.077.4335.58--
P/FCF Ratio
--10.3429.006.27-
PS Ratio
0.450.570.750.860.360.94